chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the vaccine and waited half hour due to light headiness feeling drunk and woozy. I decided half because I felt bad and had severe heat throughout my body. A feeling of out-of-body. I also had joint pain that came and went. When it returned it was very painful. My toes feel swollen but they are not and they ache. I take a muscle relaxer and a nerve medication which helps to numb the pain. I have to have help to move because I hurt so bad.
p/ pt recv vax approx 19 days later devel 4-5 red bumps w/little bit of yellow in middle, pt was afebrile.
Patient complained of lightheadedness, seizing of limbs ( as if panic attach although not restricted)- more like tingling, nausea and breathing ( panic). BP taken 120/77. Patient  sat for 50 minutes and fully recovered. Left on her own
Vaccinated: 13:00 Reaction: 13:05 Pt reported dizziness, sweating, cold clammy skin, and felt like fainting Vitals: 101/53, 51, 16, O2 100% -> @13:18: 116/74, 62, 18, O2 100% Patient later denied unusual symptoms and skin was warm/dry and later stable and released from vaccination site at 13:22.
Patient said cannot lift arm; had shot since 10/11/15 and is still experiencing problem. Came to me 11/24/15
Initial report received from a physician on 18/Nov/2005.  An 11-year-old male patient developed left axillary swelling, adenopathy extending upper part of the chest wall, subjective chills and his arm was painful upon movement within 24 hours of receiving the intramuscular injection of DECAVAC, lot number U1620AA in the left deltoid on 16/Nov/2005.  There was no fever or rash.  The patient denies any illness at the time of vaccination.  Treatment and recovery status was not reported.  Follow-up information received on 13/Feb/2006 from a health care provider.  The patient recovered, and there is no additional information at this time.
Received the vaccine at approximately 4:00PM on 11/6/2021 and developed hives/rash on my chest with burning and redness approximately 12 hours later which spread to my stomach and the injection site, lasting approximately 6 hours.    Developed a fever of 101.7  18 hours after receiving injection along with a bad headache, mild chest pains, and some numbness feeling in the legs. Took advil and the fever subsided within 6 hours. Headache and mild chest pains persisted on, from 11/7 through 11/10.  On 11/10 around 7pm the headache intensified to the point that i had some blurry vision, intense pressure and felt like a migrain. I went to the emergency room and was treated and released (administered fluids and migrain medicine via iv).  Migraine subsided but recurred for at least 24 hours.  I have had daily headaches on and off since then.  12/15 migraine came back and lasted 4 hours, took Advil and migraine subsided.  12/16 migrain returned - took advil and migraine subsided.  I've never experienced migraines prior to taking the vaccine.
Large area of bruising and swelling on left arm. Bullseye about two inches in circumference. Fever started on 08/26/13 and lasted for one week (PFAPA) symptoms.
Information has been received from a physician concerning a 20 year old female with no pertinent medical history who, six weeks ago, on approximately 30-MAR-2007, was vaccinated with GARDASIL.  Concomitant therapy included birth control pills (unspecified).  Subsequently, one to two weeks later, the patient developed a rash and was seen by a dermatologist.  The patient told the physician that it was diagnosed as psoriasis and that she received a cortisone injection.  The physician is unsure if this is related to GARDSIL because he has not yet received the report from the dermatologist.  Additional information has been requested. This is in follow-up to report (s) previously submitted on6/14/2007. Initial and follow-up information has been received from a physician concerning a 17 year old (previously reported as 20 year old) female student, who on 21-MAR-2007 was vaccinated IM in the left deltoid with a first dose of GARDASIL (lot # 657737/0522U). Concomitant therapy included birth control pills (unspecified). Subsequently, one to two weeks later, the patient developed a rash and was sen by a dermatologist. The patient told the physician that it was diagnosed as psoriasis and that she received a cortisone injection. The patient developed "OC's". "The physician is unsure of this is related to GARDASIL because he has not yet received the report from the dermatologist. At the time of the report, the outcome of the patient was unknown. Additional information is not expected.
Pt received Japanese encephalitis #2 09/15/2005 and received oral typhoid #4 doses done 09/18. Pt c/o high fever, fatigue, flu like symptoms for 7-10 days RN Decreased Japanese encephalitis series symptoms (fatigue) still persist 10-25. But pt denies further fever states almost back to normal.
This is a spontaneous report obtained from a contactable nurse through a Pfizer sales representative. A patient of an unspecified age, ethnicity and gender received, on an unspecified date, PREVNAR 13 single dose, for immunization. Relevant medical history included asthma, chronic kidney disease, high cholesterol, hypertension, and osteopenia. Concomitant medications were unknown. On an unspecified date, the patient experienced multiple pimple-like spots at injection site. Patient reported that it was not painful and no swelling was noted. Clinical outcome of the event was unknown at time of this report.
Vomiting and diarrhea. Currently keeping tack of temp and symptoms. Reached out to the first nurse and will reach out to regular family doctor. So far no treatment/office visit needed.
6/23/08 Received 1st HPV. Starting 6/24/08 client experienced dizziness, nausea after eating, loss of appetite. Pt was menstruating (1st day) when she received vaccination. At the end of cycle client experienced watery blood, and now water, yellow drainage. Referred to private medical care.
Information has been received from a pharmacist concerning a patient who was vaccinated with MMR II.  Subsequently, the patient experienced a headache and chills.  The patient did seek unspecified medical attention.  The pharmacist also discussed the experiences of another patient while on therapy with MMR II (WAES#0207USA01697).  Additional information has been requested.
blisters in legs; Some redness at injection site; blisters in the roof of mouth; A spontaneous report was received from a consumer concerning a 68-years-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness, blisters in the roof of mouth and blisters in legs.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 4 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, after receiving the first dose of the Moderna COVID19 vaccine, the patient had some redness at injection site and developed blisters in the roof of the mouth 48 hours after vaccination and also in the leg, not sure when these started, but are still there. The reporter was not very sure about onset or lasting of any of the adverse reactions   No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of event(s), redness was unknown.  The outcome of event(s), blisters in the roof of mouth, blisters in legs was not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
8/11/04 2:30 PM, coughing started and by 2:39 PM, child flushed, wheezing, and having trouble breathing. Mother contacted health department per phone and was instructed to seek emergency care immediately. 2:45 PM, approximate arrival at ER; oxygen, Orapred, and nebulizer treatment. Discharged home around 4:45 PM. Orapred continued through 8/14/04.
Patient had small localized reaction for 2 days after injection that cleared. At approximately 7 days post injection she began to have another localized reaction that included reddness, swelling, pain, heat, and a dry skin tecture that progressed to cover the lateral aspect of upper left arm from shoulder to elbow. At time of examination by RN, the patient reports that size and intensity have been increasing for about 7 days.  Patient finds relief in hot shower.  No other treatments attempted at time of exam. Patient reported area may be improving, but she is unsure.   Area was outlined with marker by RN and patient was advised to see PCP for treatment if area increased in size and was not continuing to improve.  Counseled on using OTC benadryl cream if there was itching.
Patient contracted COVID-19 after initial Comirnaty vaccine series; Patient contracted COVID-19 after initial Comirnaty vaccine series; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "Patient contracted COVID-19 after initial Comirnaty vaccine series".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, Sedation, Myalgia, Arthralgia, Fever &  CoughWheeze
-vaccine administration 3/23/2004. - child complained to parent 3/24/04 sore right arm with redness around injection site and mild swelling. Also with low grade temp 99 degrees, no other complaints.
Dr received the flu shot in the hospital on Oct 11. He said prior to the shot he was feeling well. Later that night and the next day he said he felt "crummy" and that he continued to feel worse over the next several days. On 10/17 he woke up with right sided face paralysis (Bells Palsy). He was treated (antivirals) and has improved but was still resolving as of 11/10/10.
Breakthrough disease with documented varicella on 11/12/14 inspite of having documentation of both VARIVAX vaccines.
This spontaneous report as received from a nurse refers to three unspecified patients (ages and gender unknown). The patients' medical histories, concurrent conditions and concomitant medications were not provided. On 17-JUL-2017 three patients were administered M-M-R II (route, lot# and expiration date unknown) that were improperly stored and underwent a temperature excursion.  The vaccines were reconstituted with sterile diluent (STERILE DILUENT) (route, lot# and expiration date unknown) that was properly stored. No adverse events were reported. A data logger was involved.  Temperature excursion: 47 degrees F to 77 degrees F. Time frame: 4 hours 32 minutes. There were no previous temperature excursions. Additional information has been requested.
On February 15, noticing  loud ringing in the right ear, and then on the day  February 16, noticing loss hearing completely in the right ear.  Another week later, ringing also started in the left ear.
COVID related hospitalization after receiving being vaccinated with Moderna 2 doses (3/13/2021, 2/13/2021).  Admitted 3/7/22  Hospitalized 3/7/22 with stroke like symptoms (slurred speech, facial drop) and weakness with ~1 week of frequent falls. Patient had decreased po intake for the past week. Admitted for Neurologic evaluation. Received IV hydration  Tested positive for covid 3/6/22  Chest X-ray showed subtle hazy densities in lower lobe distribution  CT showed no acute abnormality  Pt was on room air and did not qualify for decadron or remdesivir    Neurologic status resolved, back to baseline   Discharged 3/8/22
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history was not reported. On 03-FEB-2015 the patient was received improperly stored VARIVAX (lot # K007979, expiration date 03-JUN-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
Tinnitus in right ear - it?s a mild tinnitus and I?m hoping it goes away
Fatigue and headache began approximately 8 hours after vaccination. Over the course of the evening my lower back and hip joints began to ache and the headaches worsened. By 10pm the same evening of the shot, I began to get chills and the body aches worsened. The next morning, the headache had lessened considerably and the body aches were mild; chills were completely gone. By noon the next day all symptoms were resolved. Not treatment was sought, I took Ibuprofen and drank tons of water.
I think you do not need further anecdotal evidence about the second Covid-19 dose, but I had the same headache, general aches, chills, low-grade fever, and fatigue reported by others, as well as an extremely swollen arm that feels very warm to the touch. My symptoms started roughly 9 hours after the shot; I slept (or tried to) that night and most of the next day. Around 36 hours later, most of the symptoms had passed. At this point (48 hours later), there's still some fatigue, the arm is still swollen, and it has now begun to itch. (It might have done so earlier.)
Right arm pain at injection site all day. As the day progressed, I developed body aches and a headache around 7pm. By 8:30 pm, I developed extreme body chills that lasted through the night until 4am. I continued to have body aches and a headache along with nausea until late afternoon the next day 1/28/2021.
Feels the pharmacist injected the vaccine into his shoulder joint/ injected the Shingrix vaccine about 1/8 of an inch belowthe shoulder joint, at a 45 degree, needle angled downwards; Pain/Severe shoulder joint pain / Pain was localized to his right shoulder joint; Could not move his right arm/ needed assistance from his left hand to move the right arm.; This case was reported by a other health professional via call center representative and described the occurrence of pain in joint involving shoulder region in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season).   On 14th August 2020, the patient received the 1st dose of Shingrix. On 14th August 2020, unknown after receiving Shingrix and not applicable after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced vaccine administered at inappropriate site. In August 2020, the patient experienced pain in joint involving shoulder region and injected limb mobility decreased. On an unknown date, the outcome of the pain in joint involving shoulder region, injected limb mobility decreased and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the pain in joint involving shoulder region and injected limb mobility decreased to be related to Shingrix.  Additional details were reported as follows: The patient received 1st dose of shingrix vaccine in his right arm and received the flu vaccine (name unknown) in his left arm.  The patient stated that pharmacist injected the Shingrix vaccine about 1/8 of an inch below the shoulder joint, at a 45 degree, needle angled downwards. The patient felt that the pharmacist injected the vaccine into his shoulder joint (vaccine administered at inappropriate site) and stated that for three days, he could not move his right arm at all because of severe shoulder joint pain and needed assistance from his left hand to move the right arm. He did not have right arm pain and the pain was localized to his right shoulder joint. The reporter consented to follow up.
The child's father came in today to have us bill the insurance for a covid test.  We had only ever filled a COVID vaccine for the patient and it was run as "no coverage" under our COVID billing for uninsured patients.  When we collected the insurance information, we got a reject that the date of birth was mismatched.  We confirmed the date of birth with the father and he gave us the date we had on file 11/01/2016.  We let the father know that the insurance was reporting that that DOB was incorrect.  The father then said try 02/12/2019.  My technician did ask which date of birth was correct and the father confirmed that the 02/12/2019 DOB was correct.  The vaccine was initiated on line with our scheduler, and the parents would have had to fill the information out on line and it would have been confirmed prior to administration by both the pharmacist at counsel, and by the immunizing  technician prior to vaccine administration.   I searched the online link site to see if the patient had received any other vaccines, and confirmed that the initial pfizer dose was given at another pharmacy on 12/05/2021.  I contacted that pharmacy and spoke to Private name and the pharmacist and he confirmed that he had the same initial and fraudulent DOB of 11/01/2016 on the patient file at his store.  He could also see that the file and form was initiated by the parent.  Based on my findings I feel confident that false information was provided by the parents to procure a vaccine that their child was not eligible for.
Skin reaction; severe bruising; January 13th 2020 and therefore the second dose was not administered; This case was reported by a pharmacist and described the occurrence of skin reaction in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 13th January 2020, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced skin reaction, contusion and incomplete course of vaccination. On an unknown date, the outcome of the skin reaction was recovered/resolved and the outcome of the contusion and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the skin reaction and contusion to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After receiving Shingrix, the patient experienced skin reaction with severe bruising. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule. The reporter did not consent to follow-up.
Low grade fever for 12 hours with moderate pain at the injection site. Tylenol administered. No follow up required.
MOUTH SORES, CANKER SORES.  STATED JUNE, JULY, AUGUST, SEPTEMBER, OCTOBER. STLL HAVE THEM BUT BETTER. HAS 3 DAYS OF ANTI VIRAL RX IN JULY. BEEN TO FAMILY DR, DENTIST AND ORAL SURGEN.
Left arm from shoulder to elbow. Throbbing pain. Increases at night while laying down.  Restricted movement in multiple directions.  Restricted activity.  Hand strength at less than half strength of before vaccine.  Arthritis type pain in elbow.  One month after pain developed, visited doctor who said to reduce activity and take Advil at 600mg. Reduction in activity does not result in one week later.  600 mg of Advil every 12 hours does help with pain but does NOT relieve all pain or restricted movement.  I have been referred to an orthopedic physician and have an appointment next week.
Large red rash appeared on my arm below where I received the shot. The rash was a little larger than a baseball. It was very itchy and felt like a bruise if I applied pressure. The rash felt similar to a bug bite.
Anaphylaxis; This spontaneous case was reported by a consumer and describes the occurrence of ANAPHYLACTIC REACTION (Anaphylaxis) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included TOCILIZUMAB (ACTEMRA) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANAPHYLACTIC REACTION (Anaphylaxis) (seriousness criterion medically significant). At the time of the report, ANAPHYLACTIC REACTION (Anaphylaxis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication provided  Very limited information regarding this event/s has been provided at this time.  Further information has been requested.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Mother reported firm area on right thigh where Pediarix vaccine was administered. He came back to clinic a week later to get it checked. At the time of that visit on 8/29/2016 he had a firm sized discrete mass about size of nickel on same spot. He was well otherwise.
Reactions none. Pt was given a second dose of Hep B instead of her second dose of HPV.
No adverse event noted. Pt was given Moderna 0.25ml, Lot: 057A22A, Exp:  11/06/2022
No additional AE details available; professional in charge of vaccine storage calling for evaluation on refrigerated products that occurred 9/5/2022. Products were administered to multiple patients. Provided initials for all patients involved.  Names of vaccines involved (including lot/e; This spontaneous report was received from professional and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided.   On 6-SEP-2022, the patient was vaccinated with improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1879864, expiration date: 19-OCT-2023, administered for prophylaxis (strength, dose, dose number and route of administration were not provided) (product storage error).  Administered dose of vaccine experienced the temperature excursion of above 46 degrees Fahrenheit (62.8F) for 8 hours.  No adverse event was reported.; Sender's Comments:  US-009507513-2209USA002722:02242106 US-009507513-2209USA002532:02242106
Itchy, painful, red rash near vaccination site starting after 24 hours after vaccination.
Moderna COVID-19 Vaccine:  Vaccine received at 1735; tachycardia in 120s, shakiness, dizziness at 1740; chest pressure at 1745, went away then returned at 1815 and lasted until 2330  BP 156/91 HR 120s @1805 Sent to ER 1820 BP 167/99 HR 120s @1825 BP 142/87 HR 100s @1845 BP 137/76 HR 90s @1920 BP 126/75 HR 80s @ 1955  Benadryl 25 mg and Tylenol 1000 mg taken at 1700 prior to injection  Second dose of Benadryl 25 mg taken at 1800
Moderna Monovalent vaccine was received by a local Pharmacy short-dated on 1/16/23.  Lot # 074B22A was given to this resident on 4/5/23, which is past the lot expiration of 3/11/23.  MD, facility, and consultant pharmacist notified on 4/7/23.  No adverse reactions exhibited or reported after receipt of this expired vaccine.  Information was provided to MD on 4/18/23 from Moderna that it was determined this expired lot # maintained the activity necessary to protect against COVID-19 virus at time of administration.  It was concluded by MD that a repeat dose would not be necessary based on this information.
Immediately after receiving the injection, he had a syncopal episode with diaphoresis for about 15-20 seconds; he was eased to floor, 911 called, AED at his side, oxygen supplied by ambu bag. Upon waking, he stated he felt weak and sweaty lying on his left side. Ambulance crew arrived. Patient on side, oriented stating, I feel like I'm going to get sick. Dizziness.